HIGHLIGHTS
- who: Liam S. Acheson and collaborators from the Department of HealthThe funders had and will not , The National Drug and Alcohol Research Centre (NDARC), the University of New South Wales, Sydney have published the paper: Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal, in the Journal: PLOS ONE of 14/01/2022
- what: Competing interests: I have read the journal`s policy and the authors of this manuscript have the following competing interests: Michael Farrell as Director of NDARC has received unrestricted funding for research purposes . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.